Preserving Patient Access to Home Infusion Act
Take action
Record your position on this measure.
Create an account to record your position, submit testimony, or contact your legislator.
Progress
Where this bill stands in the legislative process.
- Introduced
- Passed Senate
- Passed House
- To President
- Became Law
Overview
The Preserving Patient Access to Home Infusion Act aims to ensure Medicare patients can continue to receive home infusion therapy. It expands Medicare coverage to include pharmacy services and certain medications administered without a pump, and allows nurse practitioners and physician assistants to play a role in creating and reviewing care plans. The bill also clarifies payment rules for home infusion services, particularly regarding drugs not administered through pumps, and establishes a transitional payment rate for 2026.
Key provisions
- Includes pharmacy services and drug preparation/compounding as covered home infusion therapy.
- Allows nurse practitioners and physician assistants to establish and review home infusion care plans.
- Clarifies payment rules for home infusion drugs administered without a pump.
- Establishes a transitional payment amount for home infusion therapy in 2026.
- Defines ‘specified non-pump drug or biological’ to include intravenous medications not administered through pumps.
- Specifies that payment for home infusion drugs can be made regardless of whether a practitioner is physically present.
- Addresses payment for home infusion supplies furnished on the same day as the infusion therapy.
- Defines applicable items and services for payment purposes (tubing, catheters, etc.)
Who is affected
- Medicare beneficiaries
- Home infusion therapy providers
Bill text
Read the latest version inline or switch to a previous version.
Text extraction is in progress. View the official source.
Sponsors
Official sponsors from legislative records.
2 on record
Primary sponsor
Cosponsor
Arguments
Reasons offered for and against this legislation.
Arguments in favor
No arguments in favor have been submitted.
Submit yoursArguments opposed
No arguments opposed have been submitted.
Submit yours